Reconnectstudy.com

AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) announced today the closing of the licensing agreement with Palatin Technologies, Inc. for exclusive North American commercial rights to RekyndaTM (bremelanotide), an investigational product developed for on-demand...

Female Libido Enhancer  – Bremelanotide Bremelanotide is a compound that is currently under investigation for its potential uses in managing reperfusion injury, female sexual dysfunction or hemorrhagic shock. The chemical may also see success in managing...

Hope that new drug may prevent breast cancer Friday December 13 2013 The drug anastrozole could help high-risk postmenopausal women The Daily Telegraph reports on a "remarkable breast cancer drug that could save the lives of thousands of women". ...

The pharmaceutical industry attempts to medicalize female sexuality. Since Margaret Sanger launched the US birth control movement almost 100 years ago and the Pill became available 50 years later, women are supposedly free to be as lustful or aggressive...

MONDAY, Feb. 10, 2014 (HealthDay News) — The mechanics of sex may become a bit more difficult after menopause, a new study finds. But most women will continue to be sexually active as long as they feel sex is important. The study, published online...